Accessibility links

Sector

Latest news and views about Pharmaceutical

RSS

Royal Pharmaceutical Society calls for change in EU law to prohibit export of drugs where it endangers health

18 May 2012 | Paul Gershlick

The chair of the Royal Pharmaceutical Society, Lindsey Gilpin, has called for a change to the European Union laws that permit parallel exporting of products – ie the purchase of drugs from one cheaper...

Tags on this discussion:

NICE to be stripped of role of directing NHS on cost-effectiveness of drugs

18 May 2012 | Paul Gershlick

The National Institute for Health and Clinical Excellence (NICE) will be stripped of its current role of directing the National Health Service on the cost-effectiveness of drugs. NICE’s rule will be...

Tags on this discussion:

Bristol Myers Squibb loses one third of its revenue overnight as Plavix the latest blockbuster drug to fall over the patent cliff

17 May 2012 | Paul Gershlick

Bristol Myers Squibb has lost one third of its revenues overnight, as its anti-platelet therapy, Plavix, has become the latest blockbuster drug of the big pharma companies to see its patent expire. This...

Tags on this discussion:

Abiraterone drug approval granted by NICE – but at what price?

16 May 2012 | Paul Gershlick

Abiraterone, the new drug that extends the lives of people with advanced prostate cancer by three months, has been approved by the National Institute for Health and Clinical Excellence (NICE). This follows...

Tags on this discussion:

Parliament enquiry report warns of real health risks from delays in medicines

15 May 2012 | Paul Gershlick

Patients in England are suffering from dangerous shortages in supplies of medicines and the cause is wholesalers taking advantage of legitimate rights to parallel import the medicines into other countries...

Tags on this discussion:

GPs make mistakes in one in six prescriptions

15 May 2012 | Paul Gershlick

Doctors are making mistakes in an astonishing one in six prescriptions, according to a General Medical Council study of 1,200 patients. The GMC added that many of the mistakes were thankfully either minor...

Tags on this discussion:

Aneurin Bevan Health Board promises to clean up data protection practices after sending mental health patient reports to wrong people

10 May 2012 | Paul Gershlick

Aneurin Bevan Health Board has signed written undertakings to the Information Commissioner’s Office, promising to clean up its act after carelessly sending detailed psychological reports of mental health...

Tags on this discussion:

Patent cliff takes toll as Pfizer stops marketing world’s biggest selling drug

10 May 2012 | Paul Gershlick

Pfizer has announced that it is stopping marketing its Lipitor product. The cholesterol-lowering drug is the biggest selling drug in the world. But Pfizer is suffering after Lipitor's patent expired a...

Tags on this discussion:

Threat to pharma sector innovation as University of York recommends lowering of top threshold for drug costs

9 May 2012 | Paul Gershlick

At a time when innovative pharma sector companies are facing the squeeze with pressure on pricing and high costs of bringing new products to market, they have now received further bad news. The University...

Tags on this discussion:

GSK says it will not make a move for AZ as big pharma struggles to cope with patent cliff

7 May 2012 | Paul Gershlick

GSK, the biggest UK pharmaceuticals company, has ruled out a bid for the second biggest AstraZeneca. The GSK chief executive, Andrew Witty, said that such a move would be distracting. He believes that...

Tags on this discussion:

Page 1 of 111234510...Last »